There are a variety of products available for consumption on the legal cannabis market. From concentrates to edibles, there are an increasing number of consumption methods to choose from.
At Veriheal we surveyed patients that used our services to better understand the relationship between gender and consumption methods.
Responses from a nationwide cohort of cannabis patients are used to draw connections between cannabis use in self-identified women and their preference for edibles. Supporting research is also assessed in order to evaluate the validity of these claims.
*This study was conducted using patient survey data from the Veriheal platform, which operates via electronic health records that mirror those used in the traditional medical industry—which generally does not include separate fields for birth sex and self-identified gender identity in its electronic health records. Future Veriheal reporting aims to be more inclusive of transgender and gender-nonconforming people.To understand this preference we asked male and female respondents about the following:
Patients of both genders signaled a desire for feelings of relaxation and pain relief when using cannabis.
Men were slightly more likely to desire pain relief (69%) to relaxation (67%).
Women were slightly more likely to desire feeling relaxed (72%) to feeling relief from pain (69%).
The top two conditions both genders use cannabis for (trouble sleeping and chronic pain) are seen on this graph, as well as a condition where men and women significantly differ (nausea)
The survey revealed women use cannabis to treat nausea (14%) at significantly higher rates than men (8%).Women are more likely to prefer a specific CBD:THC ratio (32.5%) than men (26.2%)
1. Maha Haq; Report Analyst and Author; Advisor at Veriheal; University of Maryland, School of Pharmacy ‘21; Director of Education, NORML Los Angeles; Chairperson, Cannabis Chamber of Commerce.
2. Alexandra Harris; Report Analyst and Author; University of Maryland, School of Pharmacy ‘23; Education Manager, NORML Los Angeles.
3. Rahul Lalmalani; Report Analyst; Duke University, BSE; Biostatician & Engineer, Greenlit.LA.
4. Dr. Thomas Henke, DO, Osteopathic Medicine; Medical Review and Diligence; Advisor at Veriheal; Nova Southeastern University College of Osteopathic Medicine; Member, American Heart Association; Registered Physician, Marijuana Regulatory Agency; Member, Society of Cannabis Clinicians; Member, Cannabis Care Certification Program; Member, Minority Cannabis Business Association, Member, National Organization for the Reform of Marijuana Laws.
Sign up for our newsletter